Clinical practice guideline for the treatment of intrinsic circadian rhythm sleep-wake disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). an update for 2015

Journal of Clinical Sleep Medicine

Volumn 11, Issue 10, 2015, Pages 1199-1236

  Auger, R Robert ^a   Burgess, Helen J ^b   Emens, Jonathan S ^c   Deriy, Ludmila V ^d   Thomas, Sherene M ^d   Sharkey, Katherine M ^e  

^a MAYO CLINIC   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

^d American Academy of Sleep Medicine   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

ASWPD; Circadian rhythms; DSWPD; ISWRD; N24SWD

Indexed keywords

CYANOCOBALAMIN; HYPNOTIC AGENT; MELATONIN; MELATONIN RECEPTOR AGONIST; WAKEFULNESS PROMOTING AGENT;

ADOLESCENT; ADULT; ADVANCED SLEEP WAKE PHASE DISORDER; AGED; ARTICLE; BIOLOGICAL RHYTHM; CHILD; CIRCADIAN RHYTHM; CLINICAL PRACTICE; DAYTIME SOMNOLENCE; DELAYED SLEEP WAKE PHASE DISORDER; DEMENTIA; DEPRESSION; HUMAN; IRREGULAR SLEEP WAKE RHYTHM DISORDER; LIGHT EXPOSURE; NEUROLOGIC DISEASE; NON 24 HOUR SLEEP WAKE RHYTHM DISORDER; PATIENT CARE; PHOTOTHERAPY; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SLEEP DISORDER; SLEEP MEDICINE; SLEEP THERAPY; SLEEP TIME; SLEEP WAKING CYCLE; SYSTEMATIC REVIEW; TREATMENT DURATION; ORGANIZATION; PRACTICE GUIDELINE; SLEEP DISORDERS, CIRCADIAN RHYTHM; SLEEP WAKE DISORDERS; UNITED STATES;

ACADEMIES AND INSTITUTES; ADOLESCENT; ADULT; CHILD; HUMANS; SLEEP DISORDERS, CIRCADIAN RHYTHM; SLEEP MEDICINE SPECIALTY; SLEEP WAKE DISORDERS; UNITED STATES;

EID: 84944683082     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.5100     Document Type: Article

References (200)

1. Morgenthaler TI, Lee-Chiong T, Alessi C, et al. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report. Sleep 2007;30:1445-59.
2. Sack RL, Auckley D, Auger RR, et al. Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review. Sleep 2007;30:1460-83.
3. Sack RL, Auckley D, Auger RR, et al. Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review. Sleep 2007;30:1484-501.
4. American Academy of Sleep Medicine. International classifcation of sleep disorders, 2nd ed. Westchester, IL: American Academy of Sleep Medicine, 2005.
5. American Academy of Sleep Medicine. International classifcation of sleep disorders, 3rd ed. Darien, IL: American Academy of Sleep Medicine, 2014.
6. Borbely AA. A two process model of sleep regulation. Hum Neurobiol 1982;1:195-204.
7. Moore RY, Eichler VB. Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res 1972;42:201-6.
8. Stephan FK, Zucker I. Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Natl Acad Sci USA 1972;69:1583-6.
9. Ralph MR, Foster RG, Davis FC, Menaker M. Transplanted suprachiasmatic nucleus determines circadian period. Science 1990;247:975-8.
10. Welsh DK, Logothetis DE, Meister M, Reppert SM. Individual neurons dissociated from rat suprachiasmatic nucleus express independently phased circadian fring rhythms. Neuron 1995;14:697-706.
11. Czeisler CA, Duffy JF, Shanahan TL, et al. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 1999;284:2177-81.
12. Burgess HJ, Eastman CI. Human tau in an ultradian light-dark cycle. J Biol Rhythms 2008;23:374-6.
13. Dunlap JC, Loros JL, DeCoursey PJ. Chronobiology: biological timekeeping. Sinauer Associates, Inc., 2004.
14. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Markey SP. Light suppresses melatonin secretion in humans. Science 1980;210:1267-9.
15. St Hilaire MA, Gooley JJ, Khalsa SB, Kronauer RE, Czeisler CA, Lockley SW. Human phase response curve to a 1 h pulse of bright white light. J Physiol 2012;590:3035-45.
16. Zeitzer JM, Dijk DJ, Kronauer R, Brown E, Czeisler C. Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression. J Physiol 2000;526 Pt 3:695-702.
17. Chang AM, Santhi N, St Hilaire M, et al. Human responses to bright light of different durations. J Physiol 2012;590:3103-12.
18. Hebert M, Martin SK, Lee C, Eastman CI. The effects of prior light history on the suppression of melatonin by light in humans. J Pineal Res 2002;33:198-203.
19. Chang AM, Scheer FA, Czeisler CA. The human circadian system adapts to prior photic history. J Physiol 2011;589:1095-102.
20. Buxton OM, L'Hermite-Baleriaux M, Turek FW, van Cauter E. Daytime naps in darkness phase shift the human circadian rhythms of melatonin and thyrotropin secretion. Am J Physiol Regul Integr Comp Physiol 2000;278:R373-82.
21. Burgess HJ, Molina TA. Home lighting before usual bedtime impacts circadian timing: a feld study. Photochem Photobiol 2014;90:723-6.
22. Thapan K, Arendt J, Skene DJ. An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans. J Physiol 2001;535:261-7.
23. Brainard GC, Hanifn J P, Greeson JM, et al. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci 2001;21:6405-12.
24. Smith MR, Eastman CI. Phase delaying the human circadian clock with blue-enriched polychromatic light. Chronobiol Int 2009;26:709-25.
25. Smith MR, Revell VL, Eastman CI. Phase advancing the human circadian clock with blue-enriched polychromatic light. Sleep Med 2009;10:287-94.
26. RevMan 5.2. The Nordic Cochrane Center, The Cochrane Collaboration. Copenhagen, 2012.
27. Mundey K, Benloucif S, Harsanyi K, Dubocovich ML, Zee PC. Phase-dependent treatment of delayed sleep phase syndrome with melatonin. Sleep 2005;28:1271-8.
28. Cole RJ, Smith JS, Alcala YC, Elliott JA, Kripke DF. Bright-light mask treatment of delayed sleep phase syndrome. J Biol Rhythms 2002;17:89-101.
29. van Geijlswijk IM, van der Heijden KB, Egberts AC, Korzilius H P, Smits MG. Dose fnding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT. Psychopharmacology 2010;212:379-91.
30. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profles and summary of fndings tables. J Clin Epidemiol 2011;64:383-94.
31. Balshem H, Helfand M, Schunemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011;64:401-6.
32. Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias). J Clin Epidemiol 2011;64:407-15.
33. Guyatt GH, Oxman AD, Montori V, et al. GRADE guidelines: 5. Rating the quality of evidence-publication bias. J Clin Epidemiol 2011;64:1277-82.
34. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines 6. Rating the quality of evidence-imprecision. J Clin Epidemiol 2011;64:1283-93.
35. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 7. Rating the quality of evidence-inconsistency. J Clin Epidemiol 2011;64:1294-302.
36. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 8. Rating the quality of evidence-indirectness. J Clin Epidemiol 2011;64:1303-10.
37. Guyatt GH, Oxman AD, Sultan S, et al. GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol 2011;64:1311-6.
38. Tuunainen A, Kripke D F, Endo T. Light therapy for non-seasonal depression. Cochrane Database System Rev 2004:CD004050.
39. Dauphinais DR, Rosenthal JZ, Terman M, DiFebo HM, Tuggle C, Rosenthal NE. Controlled trial of safety and effcacy of bright light therapy vs. negative air ions in patients with bipolar depression. Psychiatry Res 2012;196:57-61.
40. Terman M, Terman JS. Light therapy for seasonal and nonseasonal depression: effcacy, protocol, safety, and side effects. CNS Spectrums 2005;10:647-63; quiz 72.
41. Ulrich V, Olesen J, Gervil M, Russell MB. Possible risk factors and precipitants for migraine with aura in discordant twin-pairs: a population-based study. Cephalalgia 2000;20:821-5.
42. Gallin PF, Terman M, Reme CE, Rafferty B, Terman JS, Burde RM. Ophthalmologic examination of patients with seasonal affective disorder, before and after bright light therapy. Am J Ophthalmol 1995;119:202-10.
43. Reme CE, Rol P, Grothmann K, Kaase H, Terman M. Bright light therapy in focus: lamp emission spectra and ocular safety. Technol Health Care 1996;4:403-13.
44. Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PloS One 2013;8:e63773.
45. Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database Systematic Rev 2002:CD001520.
46. Spadoni G, Bedini A, Rivara S, Mor M. Melatonin receptor agonists: new options for insomnia and depression treatment. CNS Neurosci Ther 2011;17:733-41.
47. Committee on the Framework for Evaluating the Safety of the Dietary Supplements FaNB, Board on Life Sciences, Institute of Medicine and National Research Council of the National Academies. Dietary supplements: a framework for evaluating safety. Washington, DC: The National Academies Press, 2005.
48. Buscemi N, Vandermeer B, Hooton N, et al. The effcacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. J Gen Intern Med 2005;20:1151-8.
49. Werneke U, Turner T, Priebe S. Complementary medicines in psychiatry: review of effectiveness and safety. Br J Psychiatry 2006;188:109-21.
50. Rubio-Sastre P, Scheer FA, Gomez-Abellan P, Madrid JA, Garaulet M. Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening. Sleep 2014;37:1715-9.
51. Seabra ML, Bignotto M, Pinto LR Jr., Tufk S. Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J Pineal Res 2000;29:193-200.
52. Hoebert M, van der Heijden KB, van Geijlswijk IM, Smits MG. Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia. J Pineal Res 2009;47:1-7.
53. Wasdell MB, Jan JE, Bomben MM, et al. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. J Pineal Res 2008;44:57-64.
54. Carr R, Wasdell MB, Hamilton D, et al. Long-term effectiveness outcome of melatonin therapy in children with treatment-resistant circadian rhythm sleep disorders. J Pineal Res 2007;43:351-9.
55. Valcavi R, Zini M, Maestroni GJ, Conti A, Portioli I. Melatonin stimulates growth hormone secretion through pathways other than the growth hormone-releasing hormone. Clin Endocrinol 1993;39:193-9.
56. Luboshitzky R, Shen-Orr Z, Nave R, Lavi S, Lavie P. Melatonin administration alters semen quality in healthy men. J Androl 2002;23:572-8.
57. van Geijlswijk IM, Mol RH, Egberts TC, Smits MG. Evaluation of sleep, puberty and mental health in children with long-term melatonin treatment for chronic idiopathic childhood sleep onset insomnia. Psychopharmacology 2011;216:111-20.
58. Ilomaki J, Paljarvi T, Korhonen MJ, et al. Prevalence of concomitant use of alcohol and sedative-hypnotic drugs in middle and older aged persons: a systematic review. Ann Pharmacother 2013;47:257-68.
59. Buscemi N, Vandermeer B, Friesen C, et al. The effcacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med 2007;22:1335-50.
60. Peron EP, Gray SL, Hanlon JT. Medication use and functional status decline in older adults: a narrative review. Am J Geriatr Pharmacother 2011;9:378-91.
61. Woolcott JC, Richardson KJ, Wiens MO et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009;169:1952-60.
62. Bakken MS, Engeland A, Engesaeter LB, Ranhoff AH, Hunskaar S, Ruths S. Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study. Eur J Clin Pharmacol 2014;70:873-80.
63. Deschenes CL, McCurry SM. Current treatments for sleep disturbances in individuals with dementia. Curr Psychiatry Reps 2009;11:20-6.
64. Hajak G, Muller WE, Wittchen HU, Pittrow D, Kirch W. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 2003;98:1371-8.
65. James SP, Mendelson WB. The use of trazodone as a hypnotic: a critical review. J Clin Psychiatry 2004;65:752-5.
66. Stone M. Mortality and antipsychotic drug use in dementia-related behavioral disorders. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 2005.
67. Moldofsky H, Musisi S, Phillipson EA. Treatment of a case of advanced sleep phase syndrome by phase advance chronotherapy. Sleep 1986;9:61-5.
68. Suhner AG, Murphy PJ, Campbell SS. Failure of timed bright light exposure to alleviate age-related sleep maintenance insomnia. J Am Geriatr Soc 2002;50:617-23.
69. Pallesen S, Nordhus IH, Skelton SH, Bjorvatn B, Skjerve A. Bright light treatment has limited effect in subjects over 55 years with mild early morning awakening. Percept Motor Skills 2005;101:759-70.
70. Lack L, Wright H, Kemp K, Gibbon S. The treatment of early-morning awakening insomnia with 2 evenings of bright light. Sleep 2005;28:616-23.
71. Lack L, Wright H. The effect of evening bright light in delaying the circadian rhythms and lengthening the sleep of early morning awakening insomniacs. Sleep 1993;16:436-43.
72. Palmer CR, Kripke D F, Savage HC Jr., Cindrich LA, Loving RT, Elliott JA. Effcacy of enhanced evening light for advanced sleep phase syndrome. Behav Sleep Med 2003;1:213-26.
73. Campbell SS, Dawson D, Anderson MW. Alleviation of sleep maintenance insomnia with timed exposure to bright light. J Am Geriatr Society 19 93;41:829-36.
74. Munch M, Scheuermaier KD, Zhang R, et al. Effects on subjective and objective alertness and sleep in response to evening light exposure in older subjects. Behav Brain Res 2011;224:272-8.
75. Ito A, Ando K, Hayakawa T, et al. Long-term course of adult patients with delayed sleep phase syndrome. Jpn J Psychiatry Neurol 1993;47:563-7.
76. Czeisler CA, Richardson GS, Coleman RM, et al. Chronotherapy: resetting the circadian clocks of patients with delayed sleep phase insomnia. Sleep 1981;4:1-21.
77. Oren DA, Wehr TA. Hypernyctohemeral syndrome after chronotherapy for delayed sleep phase syndrome. N Engl J Med 1992;327:1762.
78. Sharkey KM, Carskadon MA, Figueiro MG, Zhu Y, Rea MS. Effects of an advanced sleep schedule and morning short wavelength light exposure on circadian phase in young adults with late sleep schedules. Sleep Med 2011;12:685-92.
79. Iwamitsu Y, Ozeki Y, Konishi M, Murakami J, Kimura S, Okawa M. Psychological characteristics and the eficacy of hospitalization treatment on delayed sleep phase syndrome patients with school refusal. Sleep Biol Rhythms 2007;5:15-22.
80. de Sousa IC, Araújo IC, de Azevedo CV. The effect of a sleep hygiene education program on the sleep-wake cycle of Brazilian adolescent students. Sleep Biol Rhythms 2007;5:251-58.
81. Fargason RE, Preston T, Hammond E, May R, Gamble KL. Treatment of attention defcit hyperactivity disorder insomnia with blue wavelength light-blocking glasses. Chronophysiol Ther 2013:1-8.
82. Burkhart K, Phelps JR. Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiol Int 2009;26:1602-12.
83. Rosenthal NE, Joseph-Vanderpool JR, Levendosky AA, et al. Phase-shifting effects of bright morning light as treatment for delayed sleep phase syndrome. Sleep 1990;13:354-61.
84. Watanabe T, Kajimura N, Kato M, Sekimoto M, Takahashi K. Effects of phototherapy in patients with delayed sleep phase syndrome. Psychiatry Clin Neurosci 1999;53:231-3.
85. Lack L, Bramwell T, Wright H, Kemp K. Morning blue light can advance the melatonin rhythm in mild delayed sleep phase syndrome. Sleep Biol Rhythms 2007:78-80.
86. Ohta T, Iwata T, Kayukawa Y, Okada T. Daily activity and persistent sleep-wake schedule disorders. Progr Neuropsychopharmacol Biol Psychiatry 1992;16:529-37.
87. Mizuma H, Miyahara Y, Sakamoto T, Kotorii T, Nakazawa Y. Two cases of delayed sleep phase syndrome (DSPS). Jpn J Psychiatry Neurol 1991;45:163-64.
88. Yamadera H, Takahashi K, Okawa M. A multicenter study of sleep-wake rhythm disorders: therapeutic effects of vitamin B12, bright light therapy, chronotherapy and hypnotics. Psychiatry Clin Neurosci 1996;50:203-9.
89. Walsh JK, Deacon S, Dijk DJ, Lundahl J. The selective extrasynaptic GABAA agonist, gaboxadol, improves traditional hypnotic effcacy measures and enhances slow wave activity in a model of transient insomnia. Sleep 2007;30:593-602.
90. Kayumov L, Brown G, Jindal R, Buttoo K, Shapiro CM. A randomized, double-blind, placebo-controlled crossover study of the effect of exogenous melatonin on delayed sleep phase syndrome. Psychosom Med 2001;63:40-8.
91. Dahlitz M, Alvarez B, Vignau J, English J, Arendt J, Parkes JD. Delayed sleep phase syndrome response to melatonin. Lancet 1991;337:1121-4.
92. Dagan Y, Yovel I, Hallis D, Eisenstein M, Raichik I. Evaluating the role of melatonin in the long-term treatment of delayed sleep phase syndrome (DSPS). Chronobiol Int 1998;15:181-90.
93. Rahman SA, Kayumov L, Shapiro CM. Antidepressant action of melatonin in the treatment of delayed sleep phase syndrome. Sleep Med 2010;11:131-6.
94. Kennaway DJ. Potential safety issues in the use of the hormone melatonin in paediatrics. J Paediatr Child Health 2015;51:584-9.
95. Van der Heijden KB, Smits MG, Van Someren EJ, Ridderinkhof KR, Gunning WB. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. J Am Acad Child Adolesc Psychiatry 2007;46:233-41.
96. Smits MG, Nagtegaal EE, van der Heijden J, Coenen AM, Kerkhof GA. Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial. J Child Neurol 2001;16:86-92.
97. Okawa M, Takahashi K, Egashira K, et al. Vitamin B12 treatment for delayed sleep phase syndrome: a multi-center double-blind study. Psychiatry Clin Neurosci 1997;51:275-9.
98. Bjorvatn B, Pallesen S. A practical approach to circadian rhythm sleep disorders. Sleep Med Rev 2009;13:47-60.
99. Figueiro MG, Rea MS. Preliminary evidence that light through the eyelids can suppress melatonin and phase shift dim light melatonin onset. BMC Res Notes 2012;5:221.
100. Revell VL, Burgess HJ, Gazda CJ, Smith MR, Fogg LF, Eastman CI. Advancing human circadian rhythms with afternoon melatonin and morning intermittent bright light. J Clin Endocrinol Metab 2006;91:54-9.
101. Burke TM, Markwald RR, Chinoy ED, et al. Combination of light and melatonin time cues for phase advancing the human circadian clock. Sleep 2013;36:1617-24.
102. Paul MA, Gray GW, Lieberman HR. et al. Phase advance with separate and combined melatonin and light treatment. Psychopharmacology 2011;214:515-23.
103. Samaranayake CB, Fernando A, Warman G. Outcome of combined melatonin and bright light treatments for delayed sleep phase disorder. Royal Aust NZ J Psychiatry 2010;44:676.
104. Gradisar M, Dohnt H, Gardner G, et al. A randomized controlled trial of cognitive-behavior therapy plus bright light therapy for adolescent delayed sleep phase disorder. Sleep 2011;34:1671-80.
105. Sack RL, Lewy AJ, Blood ML, Keith LD, Nakagawa H. Circadian rhythm abnormalities in totally blind people: incidence and clinical signifcance. J Clin Endocrinol Metab 1992;75:127-34.
106. Czeisler CA, Shanahan TL, Klerman EB, et al. Suppression of melatonin secretion in some blind patients by exposure to bright light. N Engl J Med 1995;332:6-11.
107. Danilenko KV, Cajochen C, Wirz-Justice A. Is sleep per se a zeitgeber in humans? J Biol Rhythms 2003;18:170-8.
108. Gordijn MC, Beersma DG, Korte HJ, van den Hoofdakker RH. Effects of light exposure and sleep displacement on dim light melatonin onset. J Sleep Res 1999;8:163-74.
109. Hoban TM, Lewy AJ, Sack RL, Singer CM. The effects of shifting sleep two hours within a fxed photoperiod. J Neural Transm 1991;85:61-8.
110. Buxton OM, Lee CW, L'Hermite-Baleriaux M, Turek FW, Van Cauter E. Exercise elicits phase shifts and acute alterations of melatonin that vary with circadian phase. Am J Physiol Regul Integr Comp Physiol 2003;284:R714-24.
111. Klerman EB, Rimmer DW, Dijk DJ, Kronauer RE, Rizzo JF 3rd, Czeisler CA. Nonphotic entrainment of the human circadian pacemaker. Am J Physiol 1998;274:R991-6.
112. Oren DA, Giesen HA, Wehr TA. Restoration of detectable melatonin after entrainment to a 24-hour schedule in a 'free-running' man. Psychoneuroendocrinology 1997;22:39-52.
113. Hoban TM, Sack RL, Lewy AJ, Miller LS, Singer CM. Entrainment of a free-running human with bright light? Chronobiol Int 1989;6:347-53.
114. Watanabe T, Kajimura N, Kato M, Sekimoto M, Hori T, Takahashi K. Case of a non-24 h sleep-wake syndrome patient improved by phototherapy. Psychiatry Clin Neurosci 2000;54:369-70.
115. Okawa M, Uchiyama M, Ozaki S, et al. Melatonin treatment for circadian rhythm sleep disorders. Psychiatry Clin Neurosci 1998;52:259-60.
116. Hayakawa T, Kamei Y, Urata J, et al. Trials of bright light exposure and melatonin administration in a patient with non-24 hour sleep-wake syndrome. Psychiatry Clin Neurosci 1998;52:261-2.
117. Klerman EB, Shanahan TL, Brotman DJ, et al. Photic resetting of the human circadian pacemaker in the absence of conscious vision. J Biol Rhythms 2002;17:548-55.
118. Arendt J, Aldhous M, Wright J. Synchronisation of a disturbed sleep-wake cycle in a blind man by melatonin treatment. Lancet 1988;1:772-3.
119. Folkard S, Arendt J, Aldhous M, Kennett H. Melatonin stabilises sleep onset time in a blind man without entrainment of cortisol or temperature rhythms. Neurosci Lett 1990;113:193-8.
120. Lapierre O, Dumont M. Melatonin treatment of a non-24-hour sleep-wake cycle in a blind retarded child. Biol Psychiatry 1995;38:119-22.
121. Tzischinsky O, Pal I, Epstein R, Dagan Y, Lavie P. The importance of timing in melatonin administration in a blind man. J Pineal Res 1992;12:105-8.
122. Lockley SW, Skene DJ, James K, Thapan K, Wright J, Arendt J. Melatonin administration can entrain the free-running circadian system of blind subjects. J Endocrinol 2000;164:R1-6.
123. Sack RL, Brandes RW, Kendall AR, Lewy AJ. Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med 2000;343:1070-7.
124. Hack LM, Lockley SW, Arendt J, Skene DJ. The effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjects. J Biol Rhythms 2003;18:420-9.
125. Lewy AJ, Bauer VK, Hasler BP, Kendall AR, Pires ML, Sack RL. Capturing the circadian rhythms of free-running blind people with 0.5 mg melatonin. Brain Res 2001;918:96-100.
126. Lewy AJ, Hasler BP, Emens JS, Sack RL. Pretreatment circadian period in free-running blind people may predict the phase angle of entrainment to melatonin. Neurosci Lett 2001;313:158-60.
127. Lewy AJ, Emens JS, Sack RL, Hasler BP, Bernert RA. Low, but not high, doses of melatonin entrained a free-running blind person with a long circadian period. Chronobiol Int 2002;19:649-58.
128. Lewy AJ, Emens JS, Lefer BJ, Yuhas K, Jackman AR. Melatonin entrains free-running blind people according to a physiological dose-response curve. Chronobiol Int 2005;22:1093-106.
129. Lewy AJ, Emens JS, Bernert RA, Lefer BJ. Eventual entrainment of the human circadian pacemaker by melatonin is independent of the circadian phase of treatment initiation: clinical implications. J Biol Rhythms 2004;19:68-75.
130. Siebler M, Steinmetz H, Freund HJ. Therapeutic entrainment of circadian rhythm disorder by melatonin in a non-blind patient. J Neurol 1998;245:327-8.
131. Kamei Y, Hayakawa T, Urata J, et al. Melatonin treatment for circadian rhythm sleep disorders. Psychiatry Clin Neurosci 2000;54:381-2.
132. McArthur AJ, Lewy AJ, Sack RL. Non-24-hour sleep-wake syndrome in a sighted man: circadian rhythm studies and effcacy of melatonin treatment. Sleep 1996;19:544-53.
133. Okawa M, Mishima K, Nanami T, et al. Vitamin B12 treatment for sleep-wake rhythm disorders. Sleep 1990;13:15-23.
134. Ohta T, Ando K, Iwata T, et al. Treatment of persistent sleep-wake schedule disorders in adolescents with methylcobalamin (vitamin B12). Sleep 1991;14:414-8.
135. Kamgar-Parsi B, Wehr TA, Gillin JC. Successful treatment of human non-24-hour sleep-wake syndrome. Sleep 1983;6:257-64.
136. Sugita Y, Ishikawa H, Mikami A, et al. Successful treatment for a patient with hypernychthermal syndrome. Sleep Res 1987:642.
137. Mishima K, Okawa M, Hishikawa Y, Hozumi S, Hori H, Takahashi K. Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiatr Scand 1994;89:1-7.
138. Fetveit A, Bjorvatn B. The effects of bright-light therapy on actigraphical measured sleep last for several weeks post-treatment. A study in a nursing home population. J Sleep Res 2004;13:153-8.
139. Ancoli-Israel S, Gehrman P, Martin JL, et al. Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer's disease patients. Behav Sleep Med 2003;1:22-36.
140. Ancoli-Israel S, Martin JL, Kripke DF, Marler M, Klauber MR Effect of light treatment on sleep and circadian rhythms in demented nursing home patients. J Am Geriatr Soc 2002;50:282-9.
141. Skjerve A, Holsten F, Aarsland D, Bjorvatn B, Nygaard HA, Johansen IM. Improvement in behavioral symptoms and advance of activity acrophase after short-term bright light treatment in severe dementia. Psychiatry Clin Neurosci 2004;58:343-7.
142. Dowling GA, Hubbard EM, Mastick J, Luxenberg JS, Burr RL, Van Someren EJ. Effect of morning bright light treatment for rest-activity disruption in institutionalized patients with severe Alzheimer's disease. Int Psychogeriatr 2005;17:221-36.
143. Van Someren EJ, Kessler A, Mirmiran M, Swaab D F. Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry 1997;41:955-63.
144. Fetveit A, Skjerve A, Bjorvatn B. Bright light treatment improves sleep in institutionalised elderly-an open trial. Int J Geriatr Psychiatry 2003;18:520-6.
145. Satlin A, Volicer L, Ross V, Herz L, Campbell S. Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease. Am J Psychiatry 1992;149:1028-32.
146. Dowling GA, Burr RL, Van Someren EJ, et al. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. J Am Geriatr Soc 2008;56:239-46.
147. Riemersma-van der Lek RF, Swaab DF, Twisk J, Hol EM, Hoogendijk WJ, Van Someren EJ. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA 2008;299:2642-55.
148. Greenblatt DJ, Harmatz JS, Singh NN, et al. Pharmacokinetics of zolpidem from sublingual zolpidem tartrate tablets in healthy elderly versus non-elderly subjects. Drugs Aging 2014;31:731-6.
149. Berry SD, Lee Y, Cai S, Dore DD. Nonbenzodiazepine sleep medication use and hip fractures in nursing home residents. JAMA Intern Med 2013;173:754-61.
150. Hartikainen S, Rahkonen T, Kautiainen H, Sulkava R. The use of psychotropics and survival in demented elderly individuals. Int Clin Psychopharmacol 2005;20:227-31.
151. Serfaty M, Kennell-Webb S, Warner J, Blizard R, Raven P. Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia. Int J Geriatr Psychiatry 2002;17:1120-7.
152. Singer C, Tractenberg RE, Kaye J, et al. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep 2003;26:893-901.
153. Pillar G, Shahar E, Peled N, Ravid S, Lavie P, Etzioni A. Melatonin improves sleep-wake patterns in psychomotor retarded children. Pediatr Neurol 2000;23:225-8.
154. Jan JE, Espezel H, Appleton RE. The treatment of sleep disorders with melatonin. Dev Med Child Neurol 1994;36:97-107.
155. Jan JE, Hamilton D, Seward N, Fast DK, Freeman RD, Laudon M. Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders. J Pineal Res 2000;29:34-9.
156. McArthur AJ, Budden SS. Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment. Dev Med Child Neurol 1998;40:186-92.
157. Wright B, Sims D, Smart S et al. Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: a randomised controlled crossover trial. J Autism Dev Disord 2011;41:175-84.
158. McCurry SM, Gibbons LE, Logsdon RG, Vitiello MV, Teri L. Nighttime insomnia treatment and education for Alzheimer's disease: a randomized, controlled trial. J Am Geriatr Soc 2005;53:793-802.
159. Alessi CA, Martin JL, Webber AP, Cynthia Kim E, Harker JO, Josephson KR. Randomized, controlled trial of a nonpharmacological intervention to improve abnormal sleep/wake patterns in nursing home residents. J Am Geriatr Soc 2005;53:803-10.
160. McCurry SM, Pike KC, Vitiello MV, Logsdon RG, Larson EB, Teri L. Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer's disease: results of a randomized, controlled trial. J Am Geriatr Soc 2011;59:1393-402.
161. Martin JL, Marler MR, Harker JO, Josephson KR, Alessi CA. A multicomponent nonpharmacological intervention improves activity rhythms among nursing home residents with disrupted sleep/wake patterns. J Gerontol A Biol Sci Med Sci 2007;62:67-72.
162. Guilleminault C, McCann CC, Quera-Salva M, Cetel M. Light therapy as treatment of dyschronosis in brain impaired children. Eur J Pediatr 1993;152:754-9.
163. Auger RR. Advance-related sleep complaints and advanced sleep phase disorder. Sleep Med Clin 2009;4:219-27.
164. Kondo M, Tokura H, Wakamura T, et al. Infuences of twilight on diurnal variation of core temperature, its nadir, and urinary 6-hydroxymelatonin sulfate during nocturnal sleep and morning drowsiness. Coll Antropol 2009;33:193-9.
165. Fromm E, Horlebein C, Meergans A, Niesner M, Randler C. Evaluation of a dawn simulator in children and adolescents. Biol Rhythm Res 2011;42:417-25.
166. Terman M, Jiuan Su T. Circadian rhythm phase advance with dawn simulation treatment for winter depression. J Biol Rhythms 2010;25:297-301.
167. Higuchi S, Motohashi Y, Ishibashi K, Maeda T. Less exposure to daily ambient light in winter increases sensitivity of melatonin to light suppression. Chronobiol Int 2007;24:31-43.
168. Braam W, van Geijlswijk I, Keijzer H, Smits MG, Didden R, Curfs LM. Loss of response to melatonin treatment is associated with slow melatonin metabolism. J Intellect Disabil Res 2010;54:547-55.
169. Lockley SW, Dressman MA, Licamele L, et al. Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials. Lancet 2015 Aug 4. [Epub ahead of print].
170. Richardson GS, Zee PC, Wang-Weigand S, Rodriguez L, Peng X. Circadian phase-shifting effects of repeated ramelteon administration in healthy adults. J Clin Sleep Med 2008;4:456-61.
171. Rajaratnam SM, Polymeropoulos MH, Fisher DM, et al. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. Lancet 2009;373:482-91.
172. Burgess HJ, Revell VL, Molina TA, Eastman CI. Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg. J Clin Endocrinol Metab 2010;95:3325-31.
173. Shibui K, Uchiyama M, Okawa M. Melatonin rhythms in delayed sleep phase syndrome. J Biol Rhythms 1999;14:72-6.
174. Ozaki S, Uchiyama M, Shirakawa S, Okawa M. Prolonged interval from body temperature nadir to sleep offset in patients with delayed sleep phase syndrome. Sleep 1996;19:36-40.
175. Watanabe T, Kajimura N, Kato M, et al. Sleep and circadian rhy thm disturbances in patients with delayed sleep phase syndrome. Sleep 2003;26:657-61.
176. Uchiyama M, Okawa M, Shibui K, et al. Altered phase relation between sleep timing and core body temperature rhythm in delayed sleep phase syndrome and non-24-hour sleep-wake syndrome in humans. Neurosci Lett 2000;294:101-4.
177. Wyatt JK, Stepanski EJ, Kirkby J. Circadian phase in delayed sleep phase syndrome: predictors and temporal stability across multiple assessments. Sleep 2006;29:1075-80.
178. Chang AM, Reid KJ, Gourineni R, Zee PC. Sleep timing and circadian phase in delayed sleep phase syndrome. J Biol Rhythms 2009;24:313-21.
179. Jenni OG, Achermann P, Carskadon MA. Homeostatic sleep regulation in adolescents. Sleep 2005;28:1446-54.
180. Uchiyama M, Okawa M, Shibui K et al. Poor compensatory function for sleep loss as a pathogenic factor in patients with delayed sleep phase syndrome. Sleep 2000;23:553-8.
181. Asaoka A, Fukuda K, Tsutsui Y, Yamazaki K. Does television viewing cause delayed and/or irregularsleep-wake patterns? Sleep Biol Rhythms 2007;5:23-27.
182. Crowley SJ, Acebo C, Carskadon MA. Sleep, circadian rhythms, and delayed phase in adolescence. Sleep Med 2007;8:602-12.
183. Carskadon MA. Patterns of sleep and sleepiness in adolescents. Pediatrician 1990;17:5-12.
184. Wyatt JK. Delayed sleep phase syndrome: pathophysiology and treatment options. Sleep 2004;27:1195-203.
185. Peixoto CA, da Silva AG, Carskadon MA, Louzada FM. Adolescents living in homes without electric lighting have earlier sleep times. Behav Sleep Med 2009;7:73-80.
186. Vollmer C, Michel U, Randler C. Outdoor light at night (LAN) is correlated with eveningness in adolescents. Chronobiol Int 2012;29:502-8.
187. Cajochen C, Frey S, Anders D, et al. Evening exposure to a light-emitting diodes (LED)-backlit computer screen affects circadian physiology and cognitive performance. J Appl Physiol 2011;110:1432-8.
188. Figueiro MG, Rea MS. Evening daylight may cause adolescents to sleep less in spring than in winter. Chronobiol Int 2010;27:1242-58.
189. Taylor A, Wright HR, Lack LC. Sleeping-in on the weekend delays circadian phase and increases sleepiness the following week. Sleep Biol Rhythms 2008;6:172-79.
190. Burgess HJ, Eastman CI. A late wake time phase delays the human dim light melatonin rhythm. Neurosci Lett 2006;395:191-5.
191. Crowley SJ, Carskadon MA. Modifcations to weekend recovery sleep delay circadian phase in older adolescents. Chronobiol Int 2010;27:1469-92.
192. Auger RR, Burgess HJ, Dierkhising RA, Sharma RG, Slocumb NL. Light exposure among adolescents with delayed sleep phase disorder: a prospective cohort study. Chronobiol Int 2011;28:911-20.
193. Figueiro MG, Rea MS. Lack of short-wavelength light during the school day delays dim light melatonin onset (DLMO) in middle school students. Neuroendocrinol Lett 2010;31:92-6.
194. Dagan Y, Abadi J. Sleep-wake schedule disorder disability: a lifelong untreatable pathology of the circadian time structure. Chronobiol Int 2001;18:1019-27.
195. Miller NL, Tvaryanas AP, Shattuck LG. Accommodating adolescent sleep-wake patterns: the effects of shifting the timing of sleep on training effectiveness. Sleep 2012;35:1123-36.
196. National Sleep Foundation. 2006 Sleep in America Poll Summary Findings, Washington, DC: National Sleep Foundation, 2006.
197. Wahlstrom K. Changing times: fndings from the frst longitudinal study of later school start times. NAASP Bull 2002;86:3-21.
198. Danner F, Phillips B. Adolescent sleep, school start times, and teen motor vehicle crashes. J Clin Sleep Med 2008;4:533-5.
199. Owens JA, Belon K, Moss P. Impact of delaying school start time on adolescent sleep, mood, and behavior. Arch Pediatr Adolesc Med 2010;164:608-14.
200. Wahlstrom K. The prickly politics of school starting times. Phi Delta Kappa 1999;80:344-47.